PMID:12690433

Citation	Wu, CL, Hung, CR, Chang, FY, Pau, KY and Wang, PS (2003) Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats. Naunyn Schmiedebergs Arch. Pharmacol. 367:406-13
Abstract	The effects of oxytocin (OT) on gastric emptying, gastrointestinal transit, and plasma levels of cholecystokinin (CCK) were studied in female rats. Gastrointestinal motility was assessed in rats 15 min after intragastric instillation of a test meal containing charcoal and Na(2)(51)CrO(4). Gastric emptying was determined by measuring the amount of radiolabeled chromium contained in the small intestine as a percentage of the initial amount received. Gastrointestinal transit was evaluated by calculating the geometric center of distribution of the radiolabeled marker. Blood samples were collected for CCK radioimmunoassay. After administration of OT (0.2-0.8 mg/kg), gastric emptying and gastrointestinal transit were inhibited, whereas the plasma concentration of CCK was increased in a dose-dependent manner. Atosiban, an oxytocin receptor antagonist, effectively attenuated the OT- induced inhibition of gastric emptying and gastrointestinal transit. However, administration of atosiban alone had no effect on gastric emptying and gastrointestinal transit. The selective CCK(1) receptor antagonists, devazepide and lorglumide, effectively attenuated the OT-induced inhibition of gastric emptying and gastrointestinal transit. L-365, 260, a selective CCK(2) receptor antagonist, did not alter the OT-induced inhibition of gastric emptying and gastrointestinal transit. These results suggest that OT inhibits gastric emptying and gastrointestinal transit in female rats via a mechanism involving CCK stimulation and CCK(1) receptor activation.
Links	PubMed Online version:10.1007/s00210-003-0690-y
Keywords	Animals; Benzodiazepinones/pharmacology; Cholecystokinin/antagonists & inhibitors; Cholecystokinin/blood; Devazepide/pharmacology; Dose-Response Relationship, Drug; Female; Gastric Emptying/drug effects; Gastric Emptying/physiology; Gastrointestinal Agents/pharmacology; Gastrointestinal Transit/drug effects; Gastrointestinal Transit/physiology; Hormone Antagonists/pharmacology; Oxytocin/pharmacology; Phenylurea Compounds/pharmacology; Proglumide/analogs & derivatives; Proglumide/pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin/antagonists & inhibitors; Receptors, Cholecystokinin/physiology; Vasotocin/analogs & derivatives; Vasotocin/pharmacology
edit table

Annotations

Gene product	Qualifier	GO Term	Evidence Code	with/from	Aspect	Extension	Notes	Status
RAT:OXYR	involved_in	GO:0044058: regulation of digestive system process	ECO:0000315: mutant phenotype evidence used in manual assertion		P		Seeded From UniProt	complete
RAT:NEU1	involved_in	GO:0044058: regulation of digestive system process	ECO:0000314: direct assay evidence used in manual assertion		P		Seeded From UniProt	complete

References

See Help:References for how to manage references in GONUTS.